Treatment of Inflammatory Bowel Disease with Biologics

1. Mechanism of Action and Pharmacokinetics of Biologics
Alan C. Moss

2. Antitumor Necrosis Factor Agents in Ulcerative Colitis
Kindra Clark-Snustad, Ives Hot, Scott Lee

3. Antitumor Necrosis Factor Agents in Crohn’s Disease
Byron P. Vaughn

4. Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease
David I. Fudman, Sarah N. Flier

5. Use of Biologics in the Postoperative Management of Crohn’s Disease
Benjamin H. Click, Miguel Regueiro

6. Biologics in Pregnancy and Breastfeeding
Jill K. J. Gaidos, Sunanda V. Kane

7. Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease
Parambir S. Dulai, Corey A. Siegel

8. Therapeutic Drug Monitoring of Biologic Agents
Frank I. Scott, Mark T. Osterman

9. Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks
Afrin Kamal, Bret Lashner

10. Cessation of Biologics: Can It Be Done?
Hang Hock Shim, Cynthia H. Seow

11. Biologic Therapy in Pediatric Inflammatory Bowel Disease
Sonal Patel, Jennifer Strople

12. Infectious Complications of Biologics
Renée M. Marchioni Beery, Joshua R. Korzenik

13. Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy
Julia T. Hughes, Millie D. Long

14. Noninfectious and Nonmalignant Complications of Anti-TNF Therapy
Uni Wong, Raymond K. Cross

15. Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances
Christina Y. Ha, Asher Kornbluth

16. Anti-integrin Agents in IBD: Efficacy and Risk of Complications
Jimmy K. Limdi, Francis A. Farraye

17. Novel Agents in Inflammatory Bowel Disease
Fernando Velayos

18. Quality, Safety, and Practical Considerations of Using Biologic Therapies
Leilei Zhu, Gil Y. Melmed

Keywords: Medicine & Public Health, Gastroenterology